Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Widimsky

Showing results (191-200 of 232) with videos related to

Pageof 24
Sort By:
Journal of the American College of Cardiology|June 27, 2020
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial FibrillationPavel Osmancik, Dalibor Herman, Petr Neuzil, et al.
JACC. Cardiovascular Interventions|February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
Journal of Cardiovascular Electrophysiology|August 2, 2023
Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trialMarian Branny, Pavel Osmancik, Petr Kala, et al.
Circulation|September 13, 2019
Bleeding and New Cancer Diagnosis in Patients With AtherosclerosisJohn W Eikelboom, Stuart J Connolly, Jacqueline Bosch, et al.
The New England Journal of Medicine|November 17, 2009
Intravenous platelet blockade with cangrelor during PCIDeepak L Bhatt, A Michael Lincoff, C Michael Gibson, et al.
Circulation|March 18, 2020
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)Kevin R Bainey, Robert C Welsh, Stuart J Connolly, et al.
Lancet (London, England)|August 20, 2013
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trialStephen D Wiviott, Harvey D White, E Magnus Ohman, et al.
European Heart Journal|August 28, 2012
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Ph Gabriel Steg, Stefan K James, et al.
JACC. Cardiovascular Interventions|October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trialStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Lancet (London, England)|September 7, 2010
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trialShamir R Mehta, Jean-Francois Tanguay, John W Eikelboom, et al.
Pageof 24

Showing results (191-200 of 232) with videos related to

Sort By:
Pageof 24
Journal of the American College of Cardiology|June 27, 2020
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial FibrillationPavel Osmancik, Dalibor Herman, Petr Neuzil, et al.
JACC. Cardiovascular Interventions|February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
Journal of Cardiovascular Electrophysiology|August 2, 2023
Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trialMarian Branny, Pavel Osmancik, Petr Kala, et al.
Circulation|September 13, 2019
Bleeding and New Cancer Diagnosis in Patients With AtherosclerosisJohn W Eikelboom, Stuart J Connolly, Jacqueline Bosch, et al.
The New England Journal of Medicine|November 17, 2009
Intravenous platelet blockade with cangrelor during PCIDeepak L Bhatt, A Michael Lincoff, C Michael Gibson, et al.
Circulation|March 18, 2020
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)Kevin R Bainey, Robert C Welsh, Stuart J Connolly, et al.
Lancet (London, England)|August 20, 2013
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trialStephen D Wiviott, Harvey D White, E Magnus Ohman, et al.
European Heart Journal|August 28, 2012
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Ph Gabriel Steg, Stefan K James, et al.
JACC. Cardiovascular Interventions|October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trialStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Lancet (London, England)|September 7, 2010
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trialShamir R Mehta, Jean-Francois Tanguay, John W Eikelboom, et al.
Pageof 24